摘要
目的研究药物联合肺康复治疗在老年间质性肺炎患者中的应用效果.方法选择我院2019年1月—2021年1月收治的80例老年间质性肺炎患者作为研究对象,按照随机数字表法分为两组,每组40例.对照组采用常规药物治疗,研究组在对照组基础上加用肺康复治疗.观察并对比两组治疗前后的肺功能、呼吸困难程度、运动耐力以及生活质量.结果两组治疗前用力呼出50%肺活量时的平均呼气流速(MEF50)、第1秒用力呼气容积占用力肺活量的比值(FEV1%)、呼气流速峰值(PEF)、改良英国医学研究委员会呼吸困难量表(mMRC)评分、6 min步行距离(6MWD)以及生活质量综合评定问卷(GQOLI-74)评分比较,组间差异无统计学意义(P>0.05).治疗后,两组MEF50、PEF均快于治疗前,FEV1%均高于治疗前,且研究组MEF50、PEF均快于对照组,FEV1%高于对照组,组间差异有统计学意义(P<0.05).治疗后,两组mMRC评分低于治疗前、6MWD长于治疗前,且研究组mMRC评分低于对照组、6MWD长于对照组,组间差异有统计学意义(P<0.05).治疗后,两组GQOLI-74评分均高于治疗前,且研究组GQOLI-74评分高于对照组,组间差异有统计学意义(P<0.05).结论老年间质性肺炎患者采用药物联合肺康复治疗的临床效果显著,能够改善患者的肺功能,延长患者步行距离,减轻呼吸困难程度,提升生活质量,值得推广应用.
Objective To study the effect of drug combined with pulmonary rehabilitation treatment in elderly patients with interstitial pneumonia.Methods A total of 80 elderly patients with interstitial pneumonia admitted to our hospital from January 2019 to January 2021 were selected as the research subjects,and divided into two groups according to the random number table method,with 40 cases in each group.The control group was treated with conventional drugs,and the study group was additionally treated with pulmonary rehabilitation on the basis of the control group.The lung function,degree of dyspnea,exercise tolerance and quality of life of the two groups before and after treatment were observed and compared.Results The maximal expiratory flow at 50%of forced vital capacity(MEF50),the ratio of the forced expiratory volume in one second to the forced vital capacity(FEV1%),peak expiratory flow(PEF),modified British Medical Research Council scale(mMRC)score,6 minute walking distance(6MWD)and generic quality of life inventory-74(GQOLI-74)scores in both groups before treatment were compared,and the differences between the groups were not statistically significant(P>0.05).After treatment,MEF50 and PEF in both groups were faster than before treatment,FEV1%were higher than before treatment,and the MEF50 and PEF of the study group were faster than those of the control group,and the FEV1%was higher than that of the control group,and the differences between the two groups were statistically significant(P<0.05).After treatment,the mMRC score of the two groups was lower than that before treatment,and the 6MWD was longer than that before treatment,and the mMRC score of the study group was lower than that of the control group,and the 6MWD was longer than that of the control group,and the differences between the two groups were statistically significant(P<0.05).After treatment,the scores of GQOLI-74 in both groups were higher than those before treatment,and the score of GQOLI-74 in the study group was higher than that in the control group,and the differences between the two groups were statistically significant(P<0.05).Conclusion The clinical effect of drug combined with pulmonary rehabilitation treatment in elderly patients with interstitial pneumonia is remarkable,which can improve the lung function of patients,prolong the walking distance of patients,reduce the degree of dyspnea,and improve the quality of life,which is worthy of popularization and application.
作者
郭华
GUO Hua(Department of Respiratory Medicine,Jiaozhou Hospital of Traditional Chinese Medicine,Qingdao Shandong,266300,China)
出处
《反射疗法与康复医学》
2021年第20期47-50,共4页
Reflexology And Rehabilitation Medicine
关键词
老年间质性肺炎
药物
肺康复治疗
肺功能
生活质量
Elderly interstitial pneumonia
Drugs
Pulmonary rehabilitation treatment
Pulmonary function
Quality of life
